Poster Presentations, Session 2

Monday, October 19, 2009: 7:30 AM
Grand Ballroom, Salons 1 & 2 (Renaissance Hollywood Hotel)

* Candidate for the Lee B. Lusted Student Prize Competition

Click on the Individual Presentation Titles to view the abstract details.

Click here to view Poster Number Acronyms

* VALIDATION AND CALIBRATION OF A MODEL OF PROGRESSION OF CHRONIC DISEASE PROGRESSION: AN EXAMPLE FROM GLAUCOMA
Steven M. Kymes, Ph.D.1, Sameer V. Kotak, B., Pharm, M.S.2, Dennis L. Lambert, Ph.D.1, Dustin L. Stwalley, M.A.1, Carla J. Siegfried, M.D.1, Paul P. Lee, M.D., J.D.3, David C. Musch, Ph.D., M.P.H.4, Joel Fain, Ph.D.2 and Mae O. Gordon, Ph.D.1, (1)Washington University School of Medicine, Saint Louis, MO, (2)Pfizer, Inc., New York, NY, (3)Duke University School of Medicine, Durham, NC, (4)University of Michigan School of Medicine, Ann Arbor, MI
* DETECTING ERRORS IN A CENTRAL LABORATORY: AN EVALUATION OF AN AUTOMATED METHOD TO ASSIST IN DETECTING ERRORS IN CLINICAL TRIAL DATA
Gregory B. Strylewicz, PhD, University of Washington, Seattle, WA and Jason N. Doctor, PhD, University of Southern California, Los Angeles, CA
* CALCULATING MARKOV TRANSITION PROBABILITIES WHEN TREATMENT EFFECTS ARE REPORTED AS RELATIVE RISKS WITH A DIFFERENT CYCLE TIME
Malcolm J. Price, MSc, University of Bristol, Bristol, United Kingdom, Nicky J. Welton, PhD, Bristol University, Bristol, United Kingdom and A. E. Ades, PhD, Medical Research Council, Bristol, United Kingdom
* BAYESIAN STATISTICAL APPROACH FOR COMPARING THE CLINICAL EFFICACY OF THE PARTIAL DOPAMINERGIC AGONIST ARIPIPRAZOLE TO OTHER ANTIPSYCHOTICS
Marianne Klemp Gjertsen, MD, PhD1, Ingunn F. Tvete, PhD2, Jorund Gaasemyr, PhD1, Bent Natvig, PhD1, Tor Skomedal, MD, PhD1 and Ivar Aursnes, MD, PhD1, (1)University of Oslo, Oslo, Norway, (2)Norwegian Computing Center, Oslo, Norway
* COST-EFFECTIVENESS OF SCREENING FOR CHRONIC HEPATITIS B INFECTION IN THE UNITED STATES
Mark H. Eckman, MD, MS, Tiffany Kaiser, PharmD and Kenneth E. Sherman, MD, PhD, University of Cincinnati, Cincinnati, OH
* DISCUSSION OF CLINICAL TRIALS ON THE CANCER INFORMATION SERVICE CALL LINE
Margaret M. Byrne, PhD1, Robin Vanderpool, DrPH2 and Julie Kornfeld, MPH1, (1)University of Miami, Miami, FL, (2)University of Kentucky College of Public Health, Lexington, KY
* COST-EFFECTIVENESS OF SCREENING FOR ASYMPTOMATIC CAROTID ARTERY STENOSIS
Marjolein de Weerd, MSc1, Jacoba P. Greving, PhD1, Michiel L. Bots, PhD1 and Erik Buskens, PhD2, (1)University Medical Center Utrecht, Utrecht, Netherlands, (2)University Medical Center Groningen, Groningen, Netherlands
* IS GENETIC TESTING IN COMBINATION WITH PREVENTIVE DONEPEZIL TREATMENT FOR PATIENTS WITH AMNESTIC MILD COGNITIVE IMPAIRMENT COST- EFFECTIVE?
Sandjar Djalalov, PhD1, Jean Hai Ein Yong, MASc2, Gustavo Saposnik, MD1, Zahra Musa, MHA2, Michael Mendelson3, Katherine Siminovitch, MD4 and Jeffrey Hoch, PhD5, (1)St. Michael's Hospital, Toronto, ON, Canada, (2)Cancer Care Ontario, Toronto, ON, Canada, (3)Caledon Institute of Social Policy, Toronto, ON, Canada, (4)Mount Sinai Hospital, Toronto, ON, Canada, (5)St. Michael's Hospital, University of Toronto, Toronto, ON, Canada
* DESALINATION OF THE AMERICAN DIET: POPULATION STRATEGIES TO DECREASE SODIUM INTAKE AND THE BURDEN OF CARDIOVASCULAR DISEASE
Crystal M. Smith-Spangler, MD1, Jessie Juusola, BS2, Eva Enns, MS, PhD Candidate2, Douglas K. Owens, MD, MS1 and Alan Garber, MD, PhD1, (1)Veterans Affairs Palo Alto Health Care System and Stanford University, Stanford, CA, (2)Stanford University, Stanford, CA
* A COST-EFFECTIVENESS ANALYSIS FOR THE PREVENTION OF HOSPITAL-ACQUIRED PRESSURE ULCERS
William V. Padula, MS1, Manish K. Mishra, MD, MPH, MA2, Mary Beth Makic, PhD, RNC1 and Patrick W. Sullivan, PhD3, (1)University of Colorado, Aurora, CO, (2)Dartmouth-Hitchcock Medical Center, Lebanon, NH, (3)University of Colorado Denver School of Pharmacy, Aurora, CO
* A DECISION SUPPORT-SYSTEM FOR THE MEDIASTINAL STAGING OF NON-SMALL CELL LUNG CANCER
Manuel Luque, BS1, Francisco J. DÝez, PhD1 and Carlos Disdier, PhD2, (1)Uned, Madrid, Spain, (2)San Pedro Alcantara Hospital, Caceres, Spain
* COST-EFFECTIVENESS OF LAMIVUDINE THERAPY IN VIREMIC HEPATITIS B-INFECTED PREGNANT WOMEN FOR PREVENTION OF VERTICAL TRANSMISSION OF HEPATITIS B
Natali Aziz, MD, Stanford University, South San Francisco, CA, Phuong Nguyen, MD, MBA, Santa Clara Valley Medical Center, Santa Clara, CA, Alison Cahill, MD, Washington University, St. Louis, MO, Deborah Cohan, MD, MPH, UCSF, San Francisco, CA, Sarah Little, MD, Brigham & Women's Hospital, Boston, MA and Aaron B. Caughey, MD, MPP, MPH, PhD, University of California, San Francisco, San Francisco, CA
* EXPANDED HIV SCREENING IN THE U.S.: WHAT WILL IT COST, AND WHO WILL PAY? A BUDGET IMPACT ANALYSIS
Erika G. Martin, MPH, Yale University, New Haven, CT, A. David Paltiel, PhD, Yale University School of Medicine, New Haven, CT, Rochelle P. Walensky, MD, MPH, Harvard Medical School, Boston, MA and Bruce R. Schackman, PhD, Weill Cornell Medical College, New York, NY
* PHYSICIANS' KNOWLEDGE OF AND OPINIONS ABOUT EVIDENCE-BASED MEDICINE: CROSS-SECTIONAL STUDY
Ivar S°nb° Kristiansen, MD, PhD, MPH, Institute of Health Economics, N-0317 Oslo, Denmark Norway
* MINIMAL REQUIRED EFFECTIVENESS AND COMPLIANCE OF SURGICAL MASKS AND RESPIRATORS TO MITIGATE AN INFLUENZA A PANDEMIC
Nayer Khazeni, MD, MS1, David W. Hutton, MS1, Alan Garber, MD, PhD2 and Douglas K. Owens, MD, MS2, (1)Stanford University, Stanford, CA, (2)Veterans Affairs Palo Alto Health Care System and Stanford University, Stanford, CA
* CALORIE-POSTING LAWS: PICKING THE RIGHT MEAL MAY HAVE WEIGHTY CONSEQUENCES
Fiona E. Gispen, BA, Margaret L. Brandeau, PhD and Dena M. Bravata, MD, MS, Stanford University, Stanford, CA
* SYSTEMATIC REVIEW OF GUIDELINES ON CARDIOVASCULAR RISK ASSESSMENT
Bart S. Ferket, MD1, Ersen B. Colkesen, MD2, Jacob J. Visser, PhD, MD1, Sandra Spronk, PhD1, Roderik A. Kraaijenhagen, PhD, MD3, Coenraad K. van Kalken, PhD, MD3, Ewout W. Steyerberg, PhD4 and Myriam G.M. Hunink, PhD, MD1, (1)Erasmus MC, Rotterdam, Netherlands, (2)Academic Medical Center, Amsterdam, Netherlands, (3)NDDO Institute for Prevention and Early Diagnostics, Amsterdam, Netherlands, (4)Department of Public Health, AE 236, Rotterdam, Netherlands
* EFFECT OF EARLY REHABILITATION ON TREATMENT OUTCOMES AND MEDICAL COSTS FOR PATIENTS WITH CEREBRAL VASCULAR ACCIDENT
Hsiu-Hung Yen, Taipei Veterans General Hospital, Taipei City, Taiwan and Ching Wen Chien, Ph.D., National Yang Ming University, Taipei, Taiwan
* COST EFFECTIVENESS ANALYSIS OF ANTIFUNGAL PROPHYLAXIS IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
Deborah Braccia, DNSc, Novartis Oncology, Hoboken, NJ, Patricia W. Stone, PhD, Columbia University, New York, NY and Heather Taffet Gold, PhD, Weill Cornell Medical College, New York, NY
* WHAT IS A MACE WORTH?
Robert J. Bryg, MD, Cardiology, Sylmar, CA and David J. Bryg, PhD, Olive View-Medical Center, Sylmar, CA
* POTENTIAL SAVINGS FROM THE APPLICATION OF COMPARATIVE EFFECTIVENESS RESEARCH (CER) TO LOCALIZED PROSTATE CANCER
Daniella J. Perlroth, MD1, Dana P. Goldman, PhD2 and Alan Garber, MD, PhD1, (1)Veterans Affairs Palo Alto Health Care System and Stanford University, Stanford, CA, (2)RAND Corporation, Santa Monica, CA
* RISK ASSESSMENT AND ALTERNATIVE FOAM MATTRESS PROVISION TO PREVENT PRESSURE ULCERS IN LONG-STAY HOME CARE CLIENTS
Ba' Pham, MSc, PhD, (c)1, Anita Stern, PhD2, Jeff Poss, PhD3, Rosemarie Lourenco, CHIM, IMS4, Luciano Ieraci, MSc2, Nancy Sikich, PhD4, William Witteman, MISt2, Steven Carcone, MSc1 and Murray D. Krahn, MD, MSc2, (1)Toronto Health Economics and Technology Assessment Collaborative, Toronto, ON, Canada, (2)University of Toronto, Toronto, ON, Canada, (3)University of Waterloo, Waterloo, ON, Canada, (4)Ontario Ministry of Health and Long-Term Care, Toronto, ON, Canada
* ACUTE MYOCARDIAL INFARCTION CLINICAL GUIDELINES IMPLEMENTATION IN THE EMERGENCY ROOMS OF PUBLIC GENERAL HOSPITALS IN RIO DE JANEIRO CITY, BRAZIL
Margareth C. Portela, PhD1, Alfredo B. Teixeira, MD2, Claudia C. Escosteguy, PhD3, Marco A.C. Ara˙jo, MD4, JoŃo C.M. Brito, MD5, Carlos T.M. Pinheiro, MD6, Ana L.R. Mallet, PhD7, Artur E.C. GuimarŃes, MD2 and Sheyla M.L. Lima, PhD1, (1)Oswaldo Cruz Foundation, Rio de Janeiro, Brazil, (2)Bonsucesso General Hospital, Rio de Janeiro, Brazil, (3)Servidores do Estado Hospital, Rio de Janeiro, Brazil, (4)Souza Aguiar Municipal Hospital, Rio de Janeiro, Brazil, (5)Lourenšo Jorge Municipal Hospital, Rio de Janeiro, Brazil, (6)Salgado Filho Municipal Hospital, Rio de Janeiro, Brazil, (7)Rio de Janeiro City Health Department, Rio de Janeiro, Brazil
* ARE ALL PRESSURE ULCERS THE SAME: A TALE OF TWO ORIGINS?
Luciano Ieraci, MSc1, Ba' Pham, MSc, PhD, (c)2, Murray D. Krahn, MD, MSc1 and Anita Stern, PhD1, (1)University of Toronto, Toronto, ON, Canada, (2)Toronto Health Economics and Technology Assessment Collaborative, Toronto, ON, Canada
* METHODS FOR EFFECTIVE EVALUATION OF PAIN SCREENING FOR CANCER CARE: A REPORT TO CMS FOR THE PHYSICIAN QUALITY REPORTING INITIATIVE
Tanya G.K. Bentley, PhD1, Jennifer Malin, M.D.2, Sarah Longino3, Steven Asch, MD3, Sean O'Neill4 and Karl Lorenz, MD2, (1)Partnership for Health Analytic Research, LLC, Beverly Hills, CA, (2)Veteran's Health Administration Greater Los Angeles, Los Angeles, CA, (3)VA Greater Los Angeles Healthcare Center, Los Angeles, CA, (4)RAND Corporation, Santa Monica, CA
* BUILDING BETTER QUALITY IMPROVEMENT TEAMS USING SOCIAL NETWORK ANALYSIS
David O. Meltzer, MD, PhD1, Jeanette W. Chung, PhD2, Parham Khalili, MD2, Elizabeth Marlow, MD, MA2, Vineet Arora, MD, MA1, Glenn Schumock, PharmD, MBA3 and Ronald S. Burt, PhD2, (1)University of Chicago, Chicago, IL, (2)The University of Chicago, Chicago, IL, (3)University of Illinois at Chicago, Chicago, IL
* COMORBIDITIES AND PERCEIVED CANCER RISK
David H. Howard, PhD and Ashish Rai, MS, Emory University, Atlanta, GA
* CAN PHYSICIANS BETTER TARGET BREAST CANCER TREATMENTS TO WOMEN AGED 80 AND OLDER WITH EARLY STAGE DISEASE BY LIFE EXPECTANCY?
Mara Schonberg, MD, MPH1, Edward R. Marcantonio1, Donglin Li, MD, MPH2 and Ellen P. McCarthy, PhD, MPH1, (1)Division of General Medicine and Primary Care, Brookline, MA, (2)Beth Israel Deaconess Medical Center, Brookline, MA
* CHOOSING HOW NOT TO GET PREGNANT: EVIDENCE FROM A DISCRETE CHOICE EXPERIMENT
Rosalie C. Viney, PhD1, Stephanie Knox, BSc, BA, MPH1, Marion Haas, PhD1, Denzil G. Fiebig, PhD2, Deborah J. Street, PhD1, Edith Weisberg, MBBS3 and Deborah Bateson, MBBS3, (1)University of Technology, Sydney, Sydney, Australia, (2)University of NSW, Sydney, Australia, (3)Family Planning NSW, Sydney, Australia
* PREDICTORS OF RISK PERCEPTION AND CHOICE IN SURGICAL DECISION MAKING
Seth T. Pardo, MA and Valerie Reyna, PhD, Cornell University, Ithaca, NY
* A DECISION MODEL FOR FERTILITY PRESERVATION DECISIONS IN BREAST CANCER PATIENTS
Christine M. Duffy, MD, MPH, Brown University, Providence, RI, James G. Dolan, MD, University of Rochester, Rochester, NY and Susan M. Allen, PhD, Brown Unversity Medical School, Providence, RI
* PREFERENCE METRICS: AN EVALUATION OF MATERNAL PREFERENCES TOWARD MODE OF DELIVERY
Teresa N. Sparks, MD1, Marina Stasenko, BS2, Jillian Main, MD3, Anjali Kaimal, MD, MAS4, Vargas Juan, MD5, Kier Van Remoortere, MD5 and Aaron B. Caughey, MD, MPP, MPH, PhD5, (1)Brigham & Women's Hospital, San Francisco, CA, (2)Cornell Medical College, New York, NY, (3)Kaiser San Francisco, San Francisco, CA, (4)Massachusetts General Hospital, Harvard Medical School, Boston, MA, (5)University of California, San Francisco, San Francisco, CA
* EXPLORING HETEROGENEITY IN PARENTS' PREFERENCES FOR MEDICATION: A CASE STUDY FROM ATTENTION DEFICIT HYPERACTIVITY DISORDER
Andrew J. Lloyd, DPhil1, Paul Hodgkins, PhD2, Shona Falconer, PhD1, Edmund Sonuga Barke, PhD3, Sarah Dewilde, MSc1 and Rahul Sasane, PhD2, (1)Oxford Outcomes, Oxford, United Kingdom, (2)Shire Pharmaceuticals, Wayne, PA, (3)University of Southampton, Southamptom, United Kingdom
* HEALTH RELATED QUALITY OF LIFE OF HEPATITIS B PATIENTS
Gloria Woo, MSc1, M. Sherman, MBBCH, PHd2, Jenny Heathcote, MD3 and Murray D. Krahn, MD, MSc3, (1)Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada, (2)University Health Network, Toronto, ON, Canada, (3)University of Toronto, Toronto, ON, Canada
* LONGITUDINAL STABILITY OF LATENT CLASS ANALYSIS TYPOLOGIES
Joseph A. Johnston, MD, MSc, Denai R. Milton, MS, Khaled Sarsour, PhD and David R. Nelson, MS, Eli Lilly, Indianapolis, IN
* APPLICATION OF TIME-TRADE-OFF (TTO) METHOD TO ELICIT UTILITIES IN PATIENTS UNDERGOING WHOLE BRAIN RADIATION TREATMENT AND/OR STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASIS
Lincy S. Lal, Pharm.D, PhD1, Lesley-Ann Miller, PhD1, Stacey ByfieldDaCosta, PhD1, Eric Chang, MD1, Luisa Franzini, PhD2, Chun Feng1, Liezl Reasonda1, Rebecca Arbuckle, MS1 and John M. Swint, PhD2, (1)The University of Texas M. D. Anderson Cancer Center, Houston, TX, (2)The University of Texas School of Public Health, Houston, TX
* CONJOINT ANALYSIS FOR POPULATIONS WITH SPECIAL NEEDS: VALIDITY OF A CONJOINT ANALYSIS FOR PATIENTS WITH UNCORRECTABLE VISION IMPAIRMENT
Kevin D. Frick, PhD1, Robert W. Massof, PhD2 and Lori L. Grover, OD2, (1)Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, (2)Johns Hopkins University School of Medicine, Baltimore, MD
* USING DENSITY PLOTS TO ILLUSTRATE PREFERENCE HETEROGENEITY DERIVED USING A MIXED LOGIT MODEL OF DISCRETE CHOICE DATA
Larry D. Lynd, PhD, Carlo A. Marra, PharmD, PhD, Lindsey Colley, MSc, Maja Grubisic, MSc, Bridgette Oteng, BSc and Fawziah Marra, PharmD, University of British Columbia, Vancouver, BC, Canada
* SAMPSON: A HYBRID SIMULATION AND OPTIMIZATION MODEL FOR MANAGING SURGICAL RESOURCES AND REDUCING WAITING TIMES
Hugh Walker, PhD1, Eric Hansen, BA2 and Mark Anderson2, (1)Queen's University, Kingston, ON, Canada, (2)Walker Economics Inc., Kingston, ON, Canada
* IMPACT OF POPULATION DISTRIBUTION AND BIRTH RATE ASSUMPTIONS ON INFECTIOUS DISEASE MODEL OF MENINGOCOCCAL C DISEASE
Lisa McGarry, MPH1, Gregory Hill, BS2, Samuel Aballea, MS3, Morgan Deflin, BS4, Vivek Pawar, PhD5 and Douglas Taylor1, (1)i3 Innovus, Medford, MA, (2)i3 Innovus, 02155, MA, (3)i3 Innovus, Nanterre, France, (4)i3 Innovus, San Francisco, CA, (5)Health Economics & Outcomes Research, Medford, MA
* USING A SIMULATION MODEL TO ESTIMATE THE RELATIVE RISK OF CONTRALATERAL BREAST CANCER RISK VERSUS UNILATERAL BREAST CANCER RISK IN THE GENERAL POPULATION
Rowan Iskandar, MA, Todd M. Tuttle, MD, MS and Karen M. Kuntz, ScD, University of Minnesota, Minneapolis, MN
* ESTIMATED FETAL WEIGHT OF 4000G OR 4500G: WHAT MODE OF DELIVERY?
Teresa N. Sparks, MD1, Sarah Little, MD2, William A. Grobman, MD, MBA3, Anthony Odibo, MD, MPP, MPH, PhD4, David Stamilio, MD, MBA4 and Aaron B. Caughey, MD, MPP, MPH, PhD5, (1)Brigham & Women's Hospital, San Francisco, CA, (2)Brigham & Women's Hospital, Boston, MA, (3)Northwestern University, Chicago, IL, (4)Washington University, St. Louis, MO, (5)University of California, San Francisco, San Francisco, CA
* MODELING THE JOINT DISTRIBUTION OF SENSITIVITY AND SPECIFICITY
Tessa S.S. Genders, MSc and Myriam G.M. Hunink, PhD, MD, Erasmus MC, Rotterdam, Netherlands